comparemela.com

Latest Breaking News On - Sv health investor impact medicine fund - Page 1 : comparemela.com

Therini Bio Announces Interim Results from the Phase 1

Startup Therini Bio Lands $36M to Take Blood Protein R&D to Alzheimer s & More

Merck, Sanofi, and Eli Lilly joined the Series A financing of Therini Bio, a startup developing a drug that selectively targets fibrin as a way of reducing disease-driving inflammation in neurodegeneration and eye disorders such as diabetic macular edema. Therini is preparing to advance its lead program to clinical testing.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.